您即将离开沛嘉医疗中文官网。
您刚才点击了进入另一网站的链接。如果继续,您可能会进入由第三方运行的网站。 我们不负责对非沛嘉医疗中文官网上的内容进行审核与管控,亦不会对您在非沛嘉医疗中文网上的任何商业交易或事物承担任何责任。您使用其他网站时,必须遵循该网站的使用条款及隐私声明。 其他网站上的部分产品和信息可能并未在您所在地区或国家获得批准。
取消
继续
Brief News on Innovation
Company News Brief News on Innovation
Patient Enrollment Completed for Clinical Trial of Peijia Medical’s Shenyi® Stent Retriever
2021-02-01 16:56:03

On February 1, 2021, Peijia Medical announced that patient enrollment for clinical trial of Shenyi® Stent Retriever had been successfully completed as of January 29, 2021. Shenyi® Stent Retriever is a major product under development from the Company’s neurointerventional product line.

Shenyi® Stent Retriever is used for removing fresh thrombus in intracranial vessels in a mechanical thrombectomy procedure for patients with acute ischemic stroke. As soon as all the preparations have been made, the Company plans to submit a registration application to National Medical Products Administration (NMPA)


Top